arrow
Return

Update on cellular encapsulation

delete2018-05-06
delete15
delete
OA
AI
K
Kate E. Smith
R
Robert C. Johnson
K
Klearchos K. Papas *
DOI:10.1111/xen.12399delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
There is currently a significant disparity between the number of patients who need lifesaving transplants and the number of donated human organs. Xenotransplantation is a way to address this disparity and attempts to enable the use of xenogeneic tissues have persisted for centuries. While immunologic incompatibilities have presented a persistent impediment to their use, encapsulation may represent a way forward for the use of cell-based xenogeneic therapeutics without the need for immunosuppression. In conjunction with modern innovations such as the use of bioprinting, incorporation of immune modulating molecules into capsule membranes, and genetic engineering, the application of xenogeneic cells to treat disorders ranging from pain to liver failure is becoming increasingly realistic. The present review discusses encapsulation in the context of xenotransplantation, focusing on the current status of clinical trials, persistent issues such as antigen shedding, oxygen availability, and donor selection, and recent developments that may address these limitations.
Keywords:
macroencapsulation
microencapsulation
neurodegeneration
type 1 diabetes
xenotransplantation
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Xenotransplantation cover
Xenotransplantation
IF:
4.1
Papers:
1.9K
Citations:
1.8K

Organization

U
University of Arizona
Scholars:
3.6W
Papers: 3.2W
Citations: 980
Cited Papers

Cited Papers

In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules
err2006-11-01
err47
PREAI
errPonce, S.; Orive, G.; Hernandez, R. M.; Gascon, A. R.; Canals, J. M.; Munoz, M. T.; Pedraz, J. L.
errShare
errSave
Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys
err2005-02-17
err52
PREAI
errKomoda, H; Miyagawa, S; Omori, T; Takahagi, Y; Murakami, H; Shigehisa, T; Ito, T; Matsuda, H; Shirakura, R
errShare
errSave
Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes
err2017-10-16
err87
errOAAI
errLudwig, Barbara; Ludwig, Stefan; Steffen, Anja; Knauf, Yvonne; Zimerman, Baruch; Heinke, Sophie; Lehmann, Susann; Schubert, Undine; Schmid, Janine; Bleyer, Martina; Schoenmann, Uwe; Colton, Clark K.; Bonifacio, Ezio; Solimena, Michele; Reichel, Andreas; Schally, Andrew V.; Rotem, Avi; Barkai, Uriel; Grinberg-Rashi, Helena; Kaup, Franz-Josef; Avni, Yuval; Jones, Peter; Bornstein, Stefan R.
errShare
errSave
Islet Xenotransplantation Using Gal-Deficient Neonatal Donors Improves Engraftment and Function
err2011-12-01
err122
errOAAI
errThompson, P.; Badell, I. R.; Lowe, M.; Cano, J.; Song, M.; Leopardi, F.; Avila, J.; Ruhil, R.; Strobert, E.; Korbutt, G.; Rayat, G.; Rajotte, R.; Iwakoshi, N.; Larsen, C. P.; Kirk, A. D.
errShare
errSave
Recovery of Neurological Functions in Non-Human Primate Model of Parkinson's Disease by Transplantation of Encapsulated Neonatal Porcine Choroid Plexus Cells
err2013-01-01
err36
errOAAI
errLuo, Xian-Ming; Lin, Hai; Wang, Wei; Geaney, Marilyn S.; Law, Lee; Wynyard, Shaun; Shaikh, Shamim B.; Waldvogel, Henry; Faull, Richard L. M.; Elliott, Robert B.; Skinner, Stephen J. M.; Lee, Jacqueline E.; Tan, Paul L. -J.
errShare
errSave
errShare
errSave
Specific expression of spinal Fos after PAR-2 stimulation in mast cell-depleted rats
err2002-03-01
err0
PREAI
errAtsufumi Kawabata; Naoyuki Kawao; Ryotaro Kuroda; Hideki Itoh; Hiroyuki Nishikawa
errShare
errSave
researcher View more